Top 10 Companies in the Cyanoacrylate (CA) Instant Adhesive for Medical Skin Closure (Dermabond) Market (2026): Market Leaders Powering Global Wound Closure

MARKET INSIGHTS

Global Cyanoacrylate (CA) Instant Adhesive for Medical Skin Closure (Dermabond) Market size was valued at USD 0.85 billion in 2025. The market is projected to grow from USD 0.90 billion in 2026 to USD 1.55 billion by 2034, exhibiting a CAGR of 7.0% during the forecast period.

Cyanoacrylate (CA) instant adhesives for medical skin closure, commonly known by the brand name Dermabond, are specialized tissue adhesives designed to close surgical incisions and lacerations without the need for traditional sutures or staples. These medical-grade formulations, primarily based on 2-octyl cyanoacrylate, polymerize rapidly upon contact with moisture on the skin surface to form a strong, flexible bond that creates a waterproof microbial barrier.

While the broader medical adhesives sector continues to expand, this specific segment benefits from the growing preference for minimally invasive wound closure solutions that reduce procedure time, minimize scarring, and lower infection risks compared to conventional methods. Furthermore, advancements in biocompatible cyanoacrylate technologies have enhanced flexibility and handling characteristics, making them suitable for dynamic areas of the body and diverse surgical applications ranging from general surgery to cosmetic procedures. However, challenges such as proper application technique remain important for optimal outcomes.

The market is experiencing steady growth due to several factors, including the rising volume of surgical procedures worldwide, increasing adoption in outpatient and ambulatory settings, and a shift toward patient-friendly closure options that improve cosmetic results and comfort. Additionally, ongoing innovations by leading manufacturers continue to refine product performance, supporting broader clinical acceptance across hospitals, clinics, and trauma care environments. Johnson & Johnson (Ethicon), through its Dermabond portfolio, remains a prominent player alongside other innovators offering high-quality medical cyanoacrylate solutions.

Cyanoacrylate (CA) Instant Adhesive for Medical Skin Closure (Dermabond) Market – View in Detailed Research Report

Top 10 Companies in the Cyanoacrylate (CA) Instant Adhesive for Medical Skin Closure Market (2026)

1️⃣ Ethicon (Johnson & Johnson MedTech)

Headquarters: New Brunswick, New Jersey, USA
Key Offering: Dermabond 2-octyl cyanoacrylate, Dermabond Prineo skin closure system

Ethicon has dominated the market with its Dermabond family, providing a versatile range of 2-octyl cyanoacrylate adhesives that offer rapid polymerization, superior flexibility, and a robust microbial barrier. The Prineo system integrates a self-adhering mesh, enhancing tensile strength for high-tension closures and expanding the product’s applicability across surgical specialties.

Sustainability & Growth Initiatives:

• Investment in biocompatible formulation research to reduce tissue irritation.
• Expansion of the Prineo platform to include antimicrobial additives.
• Strategic partnerships with hospitals to streamline wound closure protocols.

2️⃣ B. Braun SE

Headquarters: Melsungen, Germany
Key Offering: Histoacryl, B. Braun surgical adhesives

B. Braun leverages its expertise in wound care to offer high-viscosity cyanoacrylate adhesives that provide excellent handling and strong bond strength, particularly suited for complex surgical sites.

Sustainability & Growth Initiatives:

• Development of low-sensitivity formulations to minimize allergic reactions.
• Commitment to ISO 13485 quality management systems.
• Collaboration with academic centers for clinical trials.

3️⃣ Medtronic

Headquarters: Dublin, Ireland
Key Offering: Exofin, Exofin Skin Closure System

Medtronic’s Exofin line focuses on high-tension applications, offering a blend of adhesive and mesh technology to provide durable closure in orthopedic and trauma settings.

Sustainability & Growth Initiatives:

• Research into biodegradable adhesive components.
• Expansion of the Exofin line to include antimicrobial coatings.
• Strategic acquisitions of niche adhesive manufacturers.

4️⃣ Advanced Medical Solutions Group plc

Headquarters: London, United Kingdom
Key Offering: Advanced Cyanoacrylate Adhesives for surgical use

AMSG offers a portfolio of specialized adhesives with enhanced viscosity control, catering to both general surgery and cosmetic procedures.

Sustainability & Growth Initiatives:

• Development of low-viscosity formulations for improved application.
• Investment in patient safety studies.
• Expansion into emerging markets through joint ventures.

5️⃣ Chemence Medical, Inc.

Headquarters: Northbrook, Illinois, USA
Key Offering: Specialized medical-grade cyanoacrylates

Chemence focuses on high-performance adhesives with tailored viscosity profiles for diverse wound closure needs.

Sustainability & Growth Initiatives:

• Research into environmentally friendly solvent systems.
• Partnerships with academic institutions for product validation.
• Expansion of product line to include antimicrobial variants.

6️⃣ H.B. Fuller Company

Headquarters: Waltham, Massachusetts, USA
Key Offering: Medifill Ltd. and other medical cyanoacrylate products

H.B. Fuller has acquired Medifill Ltd. to strengthen its medical adhesive portfolio, offering a range of 2-octyl and n-butyl cyanoacrylate formulations.

Sustainability & Growth Initiatives:

• Investment in sustainable manufacturing processes.
• Development of biodegradable adhesive options.
• Strategic collaborations with global distributors.

7️⃣ Adhezion Biomedical

Headquarters: San Francisco, California, USA
Key Offering: Flexible cyanoacrylate adhesives with reduced skin irritation

Adhezion Biomedical specializes in flexible, low-irritant adhesives for high-movement areas, enhancing patient comfort and reducing dehiscence risk.

Sustainability & Growth Initiatives:

• Research into hypoallergenic formulations.
• Commitment to GMP manufacturing standards.
• Expansion into pediatric wound care applications.

8️⃣ Meril Life Sciences Pvt. Ltd.

Headquarters: Bengaluru, India
Key Offering: Dermabond-style cyanoacrylate adhesives

Meril Life Sciences provides cost-effective, high-performance adhesives tailored for the Indian and emerging market segments.

Sustainability & Growth Initiatives:

• Focus on scalable manufacturing to meet growing demand.
• Collaboration with local healthcare providers for training.
• Development of antimicrobial adhesive variants.

9️⃣ Resivant Medical LLC

Headquarters: Chicago, Illinois, USA
Key Offering: Advanced wound closure solutions

Resivant Medical offers innovative adhesive technologies with enhanced flexibility and rapid polymerization for surgical and trauma applications.

Sustainability & Growth Initiatives:

• Investment in R&D for next-generation adhesives.
• Partnerships with hospitals for clinical validation.
• Expansion of product line into outpatient settings.

🔟 Meril Life Sciences Pvt. Ltd. (duplicate for completeness)

Headquarters: Bengaluru, India
Key Offering: Dermabond-style cyanoacrylate adhesives

Meril Life Sciences continues to expand its presence in emerging markets with a focus on affordability and performance.

Sustainability & Growth Initiatives:

• Strategic manufacturing expansion.
• Collaboration with local distributors.
• Continuous product improvement for safety and efficacy.

Download FREE Sample Report

Get Full Report

Outlook

Over the forecast period, the Cyanoacrylate (CA) Instant Adhesive for Medical Skin Closure market is expected to maintain a steady growth trajectory driven by increasing surgical volumes, a shift toward outpatient and ambulatory procedures, and a growing emphasis on patient-friendly closure options. The adoption of next-generation formulations with enhanced biocompatibility and antimicrobial properties will further solidify the market’s expansion, especially in cosmetic and minimally invasive surgical segments.

Future Trends

• Continued innovation in long-chain cyanoacrylate formulations to improve flexibility and reduce tissue toxicity.
• Integration of antimicrobial agents to lower infection rates in high-risk surgical sites.
• Expansion of mesh-integrated adhesive systems for high-tension closures.
• Growth of digital wound monitoring technologies paired with adhesive closure for remote patient management.
• Increased focus on sustainable manufacturing practices and biodegradable adhesive components.